AMGEN POSTED Q2 REVENUE OF $10.05 BLN, ABOVE THE $9.44 BLN ESTIMATE, WITH ADJUSTED EPS OF $6.29 VERSUS $5.62 EXPECTED AND ADJUSTED OPERATING INCOME OF $4.61 BLN VERSUS $4.18 BLN.

متن اصلی؛ ترجمهٔ فارسی ندارد